President Trump
White House unveils plans to reimport medicines from Canada
Unthinkable to previous administrations, but scepticism rife amid flurry of policy ideas
Another setback on pricing as Trump drops rebate plans
Follows pharma's blocking of advertising changes
Trump presses on with reference pricing plan for medicines
Proposed pilot programme to run until 2025
Hancock says “NHS not for sale” in post-Brexit US trade talks
Tensions rise as President Trump arrives for state visit
Sanofi joins Lilly in insulin price cut, but lawmakers have lost patience
Insulin price nearly tripled between 2002 and 2013
Trump budget targets rebates, out-of-pocket costs
Biotech sector welcomes end to rebates, but worries about Medicare cuts
Senate grilling makes pharma CEOs squirm, but give little ground
Some signal willingness to compromise, but oppose most radical reforms
End to middlemen rebates a major shift in US drug pricing
Puts onus on pharma, which cites rebates as biggest barrier